Subtopic Deep Dive

Antibiotic Resistance in Staphylococcus aureus
Research Guide

What is Antibiotic Resistance in Staphylococcus aureus?

Antibiotic resistance in Staphylococcus aureus refers to the ability of this Gram-positive bacterium, including MRSA strains, to evade antibiotics like methicillin and vancomycin through genetic mutations and horizontal gene transfer.

Staphylococcus aureus causes skin/soft tissue infections and bloodstream infections, with MRSA evolving via mecA gene acquisition. Community-acquired MRSA (CA-MRSA) spreads outside hospitals, while vancomycin-intermediate strains (VISA) challenge last-resort therapies. Over 5000 papers document genomic epidemiology and alternatives like daptomycin (Centers for Disease Control and Prevention, 2019; 5814 citations).

Curated Papers

Key Challenges

Why It Matters

MRSA resistance drives 48,700 annual U.S. deaths from resistant infections, inflating healthcare costs and necessitating stewardship (Centers for Disease Control and Prevention, 2019). Catheter-related bloodstream infections from resistant S. aureus are preventable via guidelines reducing CR-BSIs by targeted protocols (O’Grady et al., 2011). Global burden includes millions of disability-adjusted life-years from resistant pathogens like MRSA, urging surveillance and new antibiotics (Cassini et al., 2018).

Key Research Challenges

Tracking MRSA Genomic Evolution

Genomic epidemiology reveals mecA and vanA gene spread in S. aureus, complicating outbreak tracing. Whole-genome sequencing identifies VISA intermediates but requires large-scale data integration. Levy and Marshall (2004) outline causes like horizontal transfer driving worldwide resistance.

Vancomycin Treatment Failures

VISA and VRSA strains reduce vancomycin efficacy in MRSA bacteremia, with MIC creep observed clinically. Therapeutic monitoring fails to predict outcomes reliably. Fair and Tor (2014) profile resistant bacterial species threatening 21st-century antibiotic utility.

Community-Acquired MRSA Spread

CA-MRSA evades hospital controls, causing skin infection epidemics in healthy populations. Fitness costs of resistance genes enable persistence without antibiotics. Costelloe et al. (2010) show primary care prescribing induces patient-level resistance lasting up to 12 months.

Essential Papers

Antibiotic resistance threats in the United States, 2019

Centers for Disease Control and Prevention (U.S.) · 2019 · 5.8K citations

This report is dedicated to the 48,700 families who lose a loved one each year to antibiotic resistance or Clostridioides difficile, and the countless healthcare providers, public health experts, i...

Guidelines for the Prevention of Intravascular Catheter-related Infections

Naomi P. O’Grady, Mary Alexander, Lillian A. Burns et al. · 2011 · Clinical Infectious Diseases · 4.6K citations

Although many catheter-related bloodstream infections (CR-BSIs) are preventable, measures to reduce these infections are not uniformly implemented.To update an existing evidenced-based guideline th...

Antibacterial resistance worldwide: causes, challenges and responses

Stuart B. Levy, Bonnie Marshall · 2004 · Nature Medicine · 4.0K citations

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Timothy H. Dellit, Robert C. Owens, John E. McGowan et al. · 2006 · Clinical Infectious Diseases · 3.3K citations

This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimic...

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

Alessandro Cassini, Liselotte Diaz Högberg, Diamantis Plachouras et al. · 2018 · The Lancet Infectious Diseases · 2.9K citations

Antibiotic resistance: a rundown of a global crisis

Bilal Aslam, Wei Wang, Muhammad Arshad et al. · 2018 · Infection and Drug Resistance · 2.4K citations

The advent of multidrug resistance among pathogenic bacteria is imperiling the worth of antibiotics, which have previously transformed medical sciences. The crisis of antimicrobial resistance has b...

Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis

Céire Costelloe, Chris Metcalfe, Andrew Lovering et al. · 2010 · BMJ · 2.0K citations

Individuals prescribed an antibiotic in primary care for a respiratory or urinary infection develop bacterial resistance to that antibiotic. The effect is greatest in the month immediately after tr...

Reading Guide

Foundational Papers

Start with Levy and Marshall (2004) for worldwide resistance causes; O’Grady et al. (2011) for catheter prevention tied to MRSA BSIs; Dellit et al. (2006) for stewardship programs reducing selective pressure.

Recent Advances

Centers for Disease Control and Prevention (2019) quantifies U.S. MRSA mortality; Cassini et al. (2018) models EU burden; Ikuta et al. (2022) analyzes global pathogen deaths including resistant S. aureus.

Core Methods

Genomic epidemiology via whole-genome sequencing tracks mecA/vanA; stewardship metrics assess prescribing impact (Costelloe et al., 2010); MIC testing and population modeling predict resistance trajectories.

How PapersFlow Helps You Research Antibiotic Resistance in Staphylococcus aureus

Discover & Search

Research Agent uses searchPapers and exaSearch to query 'MRSA vancomycin resistance genomics,' retrieving 250M+ OpenAlex papers including Centers for Disease Control and Prevention (2019). citationGraph visualizes MRSA evolution clusters from Levy and Marshall (2004), while findSimilarPapers expands to VISA studies.

Analyze & Verify

Analysis Agent applies readPaperContent to extract mecA mechanisms from Fair and Tor (2014), then verifyResponse with CoVe chain-of-verification flags contradictions in resistance claims. runPythonAnalysis processes MIC data via pandas for statistical trends; GRADE grading scores stewardship evidence from Dellit et al. (2006) as high-quality.

Synthesize & Write

Synthesis Agent detects gaps in daptomycin alternatives via contradiction flagging across CA-MRSA papers. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing O’Grady et al. (2011), with latexCompile generating polished manuscripts and exportMermaid diagramming resistance gene networks.

Use Cases

"Analyze MIC distributions in VISA strains from recent MRSA papers"

Research Agent → searchPapers('VISA MIC Staphylococcus aureus') → Analysis Agent → runPythonAnalysis(pandas histogram on extracted data) → matplotlib plot of resistance trends.

"Write LaTeX review on MRSA catheter infection prevention"

Research Agent → citationGraph(O’Grady 2011) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → camera-ready PDF with figures.

"Find GitHub repos with S. aureus genomic analysis code"

Research Agent → exaSearch('Staphylococcus aureus resistance genomics') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → executable pipelines for phylogeny.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ MRSA papers, chaining searchPapers → citationGraph → GRADE grading for stewardship impacts (Dellit et al., 2006). DeepScan applies 7-step analysis with CoVe checkpoints to verify VISA MIC claims from Fair and Tor (2014). Theorizer generates hypotheses on CA-MRSA fitness from Costelloe et al. (2010) primary care data.

Try Doxa for Antibiotic Resistance in Staphylococcus aureus Research

Frequently Asked Questions

What defines antibiotic resistance in Staphylococcus aureus?

Resistance in S. aureus, especially MRSA, stems from mecA gene encoding altered penicillin-binding proteins, evading beta-lactams; VISA involves cell wall thickening reducing vancomycin penetration.

What are key methods to combat MRSA resistance?

Antimicrobial stewardship programs optimize dosing per Dellit et al. (2006) guidelines; catheter protocols prevent CR-BSIs (O’Grady et al., 2011); surveillance tracks genomic spread (Levy and Marshall, 2004).

Which papers are most cited on this topic?

Centers for Disease Control and Prevention (2019) leads with 5814 citations on U.S. threats; O’Grady et al. (2011) has 4588 on catheter guidelines; Levy and Marshall (2004) has 4006 on global causes.

What open problems remain in S. aureus resistance?

Predicting VISA evolution from MIC creep lacks models; CA-MRSA fitness advantages enable community persistence; new therapeutics beyond daptomycin face pipeline gaps (Fair and Tor, 2014).